BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12673521)

  • 1. [Examinations on the importance of the inactivation of the tumor suppressor gene p16, reactivation of the telomerase and mutation of p53 in the pathogenesis of head and neck tumors].
    Koscielny S
    Laryngorhinootologie; 2003 Mar; 82(3):197-8. PubMed ID: 12673521
    [No Abstract]   [Full Text] [Related]  

  • 2. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
    Koscielny S; V Eggeling F; Dahse R
    Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
    Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
    Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of tumor suppressor gene p53 in head and neck tumors].
    Preisler V; Kirchner S; Hagen R
    HNO; 1997 Sep; 45(9):659-62. PubMed ID: 9417443
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of aberrant p53 protein in head-neck tumors and its effect on proliferation and differentiation].
    Homann N; Andl T; Nees M; Schuhmann A; Herold-Mende C; Bosch FX
    HNO; 1993 May; 41(5):254-60. PubMed ID: 8392993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic relevance of p16 inactivation in head and neck cancer.
    Koscielny S; Dahse R; Ernst G; von Eggeling F
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(1):30-6. PubMed ID: 17085950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular biology of laryngeal squamous cell carcinoma.
    Nadal A; Cardesa A
    Virchows Arch; 2003 Jan; 442(1):1-7. PubMed ID: 12536308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase activation cooperates with inactivation of p16 in early head and neck tumorigenesis.
    Soria JC; Morat L; Commo F; Dabit D; Perie S; Sabatier L; Fouret P
    Br J Cancer; 2001 Feb; 84(4):504-11. PubMed ID: 11207046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for head and neck cancer.
    Gleich LL
    Laryngoscope; 2000 May; 110(5 Pt 1):708-26. PubMed ID: 10807351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.
    Li YR; Wu JM; Wang L; Huang X; Shi J; Hu LH
    Acta Otolaryngol; 2005 Apr; 125(4):409-14. PubMed ID: 15823813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins.
    Iwasa A; Oda Y; Kurihara S; Ohishi Y; Yasunaga M; Nishimura I; Takagi E; Kobayashi H; Wake N; Tsuneyoshi M
    Pathol Int; 2008 Dec; 58(12):757-64. PubMed ID: 19067849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Deletion of chromosome 10q--a marker for metastasis of head-neck carcinomas?].
    Bockmühl U; Schmidt S; Petersen S; Petersen I
    Laryngorhinootologie; 2000 Feb; 79(2):81-5. PubMed ID: 10738714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma.
    Bradley G; Irish J; MacMillan C; Mancer K; Witterick I; Hartwick W; Gullane P; Kamel-Reid S; Benchimol S
    Oncogene; 2001 Feb; 20(5):654-8. PubMed ID: 11313998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reactivation of telomerase in squamous epithelial carcinomas in the area of the head and neck].
    Koscielny S; Fiedler W; Dahse R; Beleites E
    Laryngorhinootologie; 2000 Sep; 79(9):551-6. PubMed ID: 11050984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
    González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
    Clin Cancer Res; 1995 Sep; 1(9):1043-9. PubMed ID: 9816078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.
    Edström S; Cvetkovska E; Westin T; Young C
    Laryngoscope; 2001 Jan; 111(1):124-30. PubMed ID: 11192880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
    Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of tumor suppressor gene p53 and Rb in patients with epidermoid carcinoma of the head and neck].
    Schipper JH; Kelker W
    HNO; 1994 May; 42(5):270-4. PubMed ID: 8050915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.